New Life Pharma LLC recalls Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06

Lack of Assurance of Sterility

Date

2026-03-11

Country

United States

Brand

New Life Pharma LLC

Product

Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06

Classification

Class II

Units

OH

Category

Drugs & medical

Source

FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in the United States

1. 2026-03-11
2. US
   Drugs & medicalClass II

   MYLAN PHARMACEUTICALS INC recalls Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan…

   Failed Dissolution Specifications

   FDA · DrugMYLAN PHARMACEUTICALS INCNationwide within the United StatesOfficial notice →
3. US
   Drugs & medicalClass I

   StuffbyNainax recalls MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7

   Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil

   FDA · DrugStuffbyNainaxProduct was distributed to 4 customers in the US.Official notice →
4. US
   Drugs & medicalClass I

   Mohamed Hagar recalls Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0

   Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).

   FDA · DrugMohamed HagarU.S. NationwideOfficial notice →
5. US
   Drugs & medicalClass II

   Radnostix recalls Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333,…

   Presence of Particulate Matter: Due to production issues

   FDA · DrugRadnostixNationwide in the USA and Puerto RicoOfficial notice →
6. US
   Drugs & medicalClass I

   ANTHONY TRINH, 123Herbals LLC recalls SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

   Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

   FDA · DrugANTHONY TRINH, 123Herbals LLCUSA nationwideOfficial notice →
7. US
   Drugs & medicalClass II

   HTO Nevada Inc. dba Kirkman recalls FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR…

   Stability Data Does Not Support Expiry Date.

   FDA · DrugHTO Nevada Inc. dba KirkmanNationwide within the U.SOfficial notice →